| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1760 | 2020 |
| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance W Roh, PL Chen, A Reuben, CN Spencer, PA Prieto, JP Miller, ... Science translational medicine 9 (379), eaah3560, 2017 | 766 | 2017 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 709 | 2018 |
| Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients LG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ... Clinical Cancer Research 18 (24), 6758-6770, 2012 | 456 | 2012 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 448 | 2021 |
| Neoadjuvant–adjuvant or adjuvant-only pembrolizumab in advanced melanoma SP Patel, M Othus, Y Chen, GP Wright Jr, KJ Yost, JR Hyngstrom, ... New England Journal of Medicine 388 (9), 813-823, 2023 | 296 | 2023 |
| Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses K Robinson, R Kenefeck, EL Pidgeon, S Shakib, S Patel, RJ Polson, ... Gut 57 (10), 1375-1385, 2008 | 294 | 2008 |
| Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised … RN Amaria, PA Prieto, MT Tetzlaff, A Reuben, MC Andrews, MI Ross, ... The Lancet Oncology 19 (2), 181-193, 2018 | 276 | 2018 |
| Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade MC Andrews, CPM Duong, V Gopalakrishnan, V Iebba, WS Chen, ... Nature medicine 27 (8), 1432-1441, 2021 | 269 | 2021 |
| Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome A Torrelo, S Patel, I Colmenero, D Gurbindo, F Lendínez, A Hernández, ... Journal of the American Academy of Dermatology 62 (3), 489-495, 2010 | 220 | 2010 |
| Neoadjuvant relatlimab and nivolumab in resectable melanoma RN Amaria, M Postow, EM Burton, MT Tetzlaff, MI Ross, C Torres-Cabala, ... Nature 611 (7934), 155-160, 2022 | 169 | 2022 |
| Hypoxia-driven immunosuppressive metabolites in the tumor microenvironment: new approaches for combinational immunotherapy Y Li, SP Patel, J Roszik, Y Qin Frontiers in immunology 9, 1591, 2018 | 167 | 2018 |
| The tardigrade Hypsibius dujardini, a new model for studying the evolution of development WN Gabriel, R McNuff, SK Patel, TR Gregory, WR Jeck, CD Jones, ... Developmental biology 312 (2), 545-559, 2007 | 148 | 2007 |
| First-in-human study of mivebresib (ABBV-075), an oral pan-inhibitor of bromodomain and extra terminal proteins, in patients with relapsed/refractory solid tumors SA Piha-Paul, JC Sachdev, M Barve, P LoRusso, R Szmulewitz, SP Patel, ... Clinical Cancer Research 25 (21), 6309-6319, 2019 | 132 | 2019 |
| Aloe–emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells M Acevedo-Duncan, C Russell, S Patel, R Patel International immunopharmacology 4 (14), 1775-1784, 2004 | 112 | 2004 |
| Helicobacter pylori dupA Is Polymorphic, and Its Active Form Induces Proinflammatory Cytokine Secretion by Mononuclear Cells NR Hussein, RH Argent, CK Marx, SR Patel, K Robinson, JC Atherton The Journal of infectious diseases 202 (2), 261-269, 2010 | 90 | 2010 |
| Effects of prophylactic antibiotics on colonic healing HH LeVeen, S Wapnick, G Falk, O Olivas, D Bhat, M Gaurdre, M Patel The American Journal of Surgery 131 (1), 47-53, 1976 | 88 | 1976 |
| The gut microbiome (GM) and immunotherapy response are influenced by host lifestyle factors CN Spencer, V Gopalakrishnan, J McQuade, MC Andrews, B Helmink, ... Cancer Research 79 (13_Supplement), 2838-2838, 2019 | 82 | 2019 |
| Advances in the clinical management of uveal melanoma RD Carvajal, JJ Sacco, MJ Jager, DJ Eschelman, R Olofsson Bagge, ... Nature Reviews Clinical Oncology 20 (2), 99-115, 2023 | 75 | 2023 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 69 | 2022 |
